Published in Cancer on August 15, 1984
Metastasis of colorectal carcinoma to the testes: clinical presentation and possible pathways. Int J Clin Oncol (2010) 1.80
Carcinoma of the sigmoid colon presenting as a scrotal swelling. Postgrad Med J (1997) 0.98
Simultaneous bilateral testicular metastases from renal clear cell carcinoma: A case report and review of the literature. Oncol Lett (2014) 0.97
Metastatic prostatic carcinoma to testis: histological features mimicking lymphoma. Int J Clin Exp Pathol (2008) 0.93
Cholangiocarcinoma presenting as a solitary epididymal metastasis: a case report and review of the literature. Diagn Pathol (2007) 0.90
Primary testicular mucinous neoplasms: case report and literature review. Can Urol Assoc J (2010) 0.89
Elevated human chorionic gonadotrophin levels in a patient with pancreatic carcinoma presenting with a testicular metastasis. Postgrad Med J (1990) 0.79
Metastatic testicular tumor presenting as a scrotal hydrocele: An initial manifestation of pancreatic adenocarcinoma. Oncol Lett (2014) 0.78
A case of descending colon carcinoma metastasized to left spermatic cord, testis, and epididymis. Cent European J Urol (2012) 0.78
Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature. BMC Endocr Disord (2014) 0.78
Malignant mesothelioma of the tunica vaginalis testis: report of a case. Surg Today (1999) 0.77
Testicular metastasis of colorectal carcinoma: an unusual presentation. BMJ Case Rep (2013) 0.75
Malignant melanoma representing with testicular metastasis: a case report and review of the literature. Can Urol Assoc J (2010) 0.75
Testicular metastasis as the first clinical manifestation of pancreatic adenocarcinoma: a case report. J Med Case Rep (2015) 0.75
Melanoma metastases in the abdomen and pelvis: Frequency and patterns of spread. World J Radiol (2013) 0.75
Primary testicular mucinous cystadenoma: Case report and literature review. Can Urol Assoc J (2015) 0.75
Patterns of metastasis from the primary site to the testes indicate the potential pathway of metastasis. Int J Clin Oncol (2015) 0.75
Testicular metastasis found in a patient with previous large bowel tumour. BMJ Case Rep (2009) 0.75
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst (2001) 4.27
Hypersensitivity reactions from taxol. J Clin Oncol (1990) 3.83
Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet (1991) 2.60
Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer (1990) 2.28
Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology (1984) 2.08
Transthoracic needle aspiration biopsy of benign and malignant lung lesions. AJR Am J Roentgenol (1985) 2.05
Psychiatric symptomatology among hospitalized cancer patients. Am J Psychiatry (1974) 1.90
Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res (1988) 1.84
Immunoperoxidase technics in diagnostic pathology. Report of a workshop sponsored by the National Cancer Institute. Am J Clin Pathol (1979) 1.84
Involvement of the heart by malignant lymphoma: a clinicopathologic study. Cancer (1982) 1.77
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol (1993) 1.76
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol (1999) 1.76
Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med (1990) 1.72
Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study. J Natl Cancer Inst (1992) 1.70
Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis (1983) 1.69
Extension of donor criteria in cardiac transplantation: surgical risk versus supply-side economics. Ann Thorac Surg (1990) 1.69
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. J Clin Oncol (1994) 1.67
Cutaneous involvement in malignant histiocytosis. Case report and review of the literature. Arch Dermatol (1981) 1.64
Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol (1989) 1.63
Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol (1997) 1.58
Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol (1991) 1.57
Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol (1994) 1.55
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol (1993) 1.50
Psychological coping mechanisms and survival time in metastatic breast cancer. JAMA (1979) 1.50
Management of locally recurrent breast cancer. Cancer (1993) 1.46
Reexcision perineural invasion. Not a sign of malignancy. Am J Surg Pathol (1990) 1.46
Malignant melanoma in xeroderma pigmentosum: search for a precursor lesion. J Am Acad Dermatol (1993) 1.44
Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. J Infect Dis (1999) 1.44
Clinical features and natural history of intramedullary spinal cord metastasis. Cancer (1985) 1.43
Fibroepithelioma of Pinkus. Eccrine duct spread of basal cell carcinoma. Am J Dermatopathol (1994) 1.43
Failure of GM-CSF to permit dose-escalation in an every other week dose-intensive regimen for advanced breast cancer. Ann Oncol (1994) 1.43
Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole. Clin Cancer Res (2000) 1.40
Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clin Cancer Res (2001) 1.35
Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol (1994) 1.34
Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet (2004) 1.32
The lung in sickle cell disease. Chest (1982) 1.31
Malignant lymphomas--a conceptual understanding of morphologic diversity. A review. Am J Pathol (1979) 1.30
1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res (1999) 1.27
Birds disperse ixodid (Acari: Ixodidae) and Borrelia burgdorferi-infected ticks in Canada. J Med Entomol (2001) 1.26
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology (1997) 1.24
High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. J Natl Cancer Inst (1991) 1.23
Changes in morphologic and biochemical characteristics of small cell carcinoma of the lung. A clinicopathologic study. Am J Med (1979) 1.22
Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture. Cancer Res (1980) 1.21
Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers. N Engl J Med (1976) 1.21
Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies. J Clin Oncol (1985) 1.20
Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res (1997) 1.20
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol (2001) 1.20
Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis. J Clin Oncol (1984) 1.20
Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem (2001) 1.19
Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations. Am J Med (1980) 1.19
Malignant lymphomas involving the prostate. A study of 13 cases. Cancer (1985) 1.18
Importance of continued testicular suppression in hormone-refractory prostate cancer. J Clin Oncol (1993) 1.18
Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood (1993) 1.16
The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med (1981) 1.16
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol (1992) 1.15
Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Clin Cancer Res (2001) 1.15
Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism (2001) 1.15
Phase I study of vinblastine and verapamil given by concurrent iv infusion. Cancer Treat Rep (1985) 1.15
Acquired extrinsic pulmonic stenosis caused by mediastinal tumors. Cancer (1982) 1.13
A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin Cancer Res (1999) 1.12
Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet (1989) 1.11
Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep (1982) 1.11
The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol (1982) 1.10
Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer (1983) 1.09
Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection. Mol Cell Probes (1993) 1.09
Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res (2001) 1.09
Factors influencing options in primary breast cancer treatment. J Clin Oncol (1987) 1.07
Corticosteroid toxicity in neuro-oncology patients. J Neurooncol (1987) 1.07
Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol (1984) 1.06
Immunologic aspects and pathology of the malignant lymphomas. Cancer (1978) 1.06
Hypercalcemia and neuroendocrine carcinoma of the prostate: a report of three cases and a review of the literature. J Clin Oncol (1992) 1.05
Compliance with cancer therapy by patients and physicians. Am J Med (1983) 1.04
A phase II study of taxol in patients with malignant melanoma. Invest New Drugs (1991) 1.04
Bromide intoxication. Johns Hopkins Med J (1976) 1.04
Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Cancer (1998) 1.03
Interaction of rifampin and warfarin. Chest (1975) 1.03
Epstein-Barr-encoded RNA in situ hybridization: diagnostic applications. Hum Pathol (1994) 1.02
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment. J Clin Oncol (1998) 1.01
The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. J Clin Endocrinol Metab (1982) 1.01
Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment. Urol Clin North Am (1992) 1.00
Ara-C lung: noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia. Am J Med (1981) 1.00
Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer. Urol Oncol (2011) 0.99
Cancer patients and their pjysicians in the perception of psychological symptoms. Psychosomatics (1976) 0.99
Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. J Urol (2001) 0.98
Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study. J Clin Oncol (1990) 0.98
Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer. Cancer Treat Rep (1986) 0.98
Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst (1998) 0.97
Pure red blood cell aplasia and chronic lymphocytic leukemia. Arch Intern Med (1974) 0.97
Spinal cord compression in prostate cancer. J Neurooncol (1995) 0.97
Inflammatory melanoma. J Am Acad Dermatol (1984) 0.95
Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications. N Engl J Med (1978) 0.95
Isolation of leukemic blasts from peripheral blood by density gradient centrifugation. J Lab Clin Med (1970) 0.95
Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography. Am J Med (1982) 0.95
Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trial. J Clin Oncol (1992) 0.95
Evaluation of pathology review of malignant lymphomas and Hodgkin's disease in cooperative clinical trials. The Eastern Cooperative Oncology Group experience. Cancer (1988) 0.95
Choice of starting dose and escalation for phase I studies of antitumor agents. Cancer Chemother Pharmacol (1992) 0.94
Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study. J Clin Oncol (1998) 0.94
Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. Cancer (1982) 0.94